Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Clarithromycin-based Regimens for Disseminated MAC in AIDS
NCT00001047Phase 3Completed
- Sponsor
- National Institute of Allergy and Infectious Diseases
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of clarithromycin in Mycobacterium avium complex infection (MAC), sponsored by National Institute of Allergy and Infectious Diseases. Status: completed.
02
Drugs
clarithromycin
03
Conditions
Mycobacterium avium complex infection (MAC)
Beyond the preview
Go deeper on NCT00001047.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00001047.